Insights into Retinal Health: Bridging Payer Gaps for Timely and Equitable Care

Pricing: Free for Members and Non-Members

Course Description

A growing number of therapeutic options for retinal diseases are on the market which reflect disease-targeted therapeutic advances for age-related wet macular degeneration, diabetic macular edema, and diabetic retinopathy. In navigating the complexities of managing patients with retinal disease, it is imperative to recognize the multifaceted barriers that hinder optimal care delivery. Key challenges encompass understanding its substantial burden on individuals and society and addressing the prevailing health disparities that impede equitable access to treatment. Faculty for this session will provide an overview of the latest drug advancements in age-related macular degeneration, diabetic macular edema, and diabetic retinopathy to align managed care strategies that support appropriate and timely treatment and bridge access and utilization of care for marginalized groups.

Target Audience

Pharmacists who practice in managed care settings.

Learning Objectives

At the completion of this activity, participants should be able to:

  1. Define age-related macular degeneration (AMD), diabetic macular edema (DME), and diabetic retinopathy (DR) and its appropriate treatment, including emerging therapeutic options, distinguishing clinical efficacy, safety, and dosing.
  2. Discuss managed care approaches to formulary and drug utilization within the medical benefit to address access to equitable care and improve outcomes for retinal disease, specifically AMD, DME, and DR.
  3. Recognize retinal disease's financial and societal impact on existing health disparities within the disease state, focusing on AMD, DME, and DR.

Commercial Support

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Course summary
Available credit: 
  • 1.25 ACPE
    ACPE The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
  • 1.25 Certificate of Completion
Course opens: 
11/11/2024
Course expires: 
12/31/2025
Cost:
$0.00

Casey R. Koch, PharmD

Clinical Pharmacy Coordinator
Select Health
Woods Cross, UT

Niket Ruparelia, PharmD

Clinical Operations Pharmacist
Zing Health
Diamond Bar, CA

Disclosures

Faculty/Reviewer/Planner​

Reported Relevant Financial Relationships​

Casey R. Koch, PharmD​

Faculty​

Disclosed no relevant financial relationships.​

Niket Ruparelia, PharmD​

Faculty​

Disclosed no relevant financial relationships.​

Tracy McDowd, PharmD, FAMCP​

Reviewer​

Disclosed no relevant financial relationships​

Brittany V. Henry, PharmD, MBA​

Planner​

Disclosed no relevant financial relationships.​

​

The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

ACPE UAN: 0233-0000-24-064-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: November 11, 2024 •  Expiration Date: December 31, 2025
Activity Fee: Free for Members and Non-Members

Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at Nexus 2024. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.

To receive credit for an online activity you must:

  • Review the full content of the activity.
  • Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
  • Complete a specific activity evaluation.

Available Credit

  • 1.25 ACPE
    ACPE The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
  • 1.25 Certificate of Completion

Price

Cost:
$0.00
Please login or register to take this course.